Dr. Donald G. Phinney's lab focuses on improving the therapeutic applications of mesenchymal stem cells (MSCs) for various human diseases. By developing a Clinical Indications Prediction (CLIP) scale, the lab aims to enhance the understanding of how donor characteristics and manufacturing processes affect the potency of MSCs. This research is crucial in creating tailored MSC therapies that yield better patient outcomes.

Dr. Lori A. Knackstedt's lab at the University of Florida focuses on understanding the effects of combining opioid and alcohol use, known as polysubstance use. This research is particularly important because it looks at how this combination worsens cognitive functions and health outcomes. By studying human behavior and creating rodent models, the lab aims to uncover the underlying mechanisms that lead to addiction and impaired cognition, which could help develop better treatments and interventions for substance use disorders.

Dr. Daniel Swale's lab at the University of Florida studies how potassium channels influence the immune response to viruses. By examining these channels in various organisms, including insects and mammals, the research aims to uncover how potassium levels affect antiviral responses and could inform new therapeutic strategies. The lab will explore the connections between ion channels, immune function, and viral replication, contributing to a better understanding of viral infections and potential interventions.

Dr. Stefan Prokop's lab at the University of Florida focuses on understanding how certain proteins in the brain contribute to Alzheimer's disease (AD). They are investigating the role of amyloid-associated proteins (AAPs) in the progression of the disease, particularly how these proteins might affect neurodegeneration over time. By studying these processes, the lab aims to identify potential new therapeutic targets to combat AD and improve patient outcomes.

Dr. Sathya Puthanveettil's lab at the University of Florida focuses on understanding the role of long non-coding RNAs (lncRNAs) in Alzheimer's disease. The lab aims to uncover how these molecules contribute to the disease's progression, particularly through their effects on synaptic function and memory. By investigating specific lncRNAs like SLAMR, the research could lead to innovative therapeutic strategies for combating Alzheimer's.

Dr. Laura P.W. Ranum's lab focuses on understanding diseases caused by repetitive DNA sequences, particularly how certain proteins related to these sequences (called RAN proteins) may contribute to neurodegenerative disorders like Huntington's disease and spinocerebellar ataxias. The lab uses advanced techniques to explore the effects of these RAN proteins on cells and developing potential treatments to inhibit their harmful effects.

Dr. Carlos M. Rinaldi-Ramos leads a research lab at the University of Florida where the focus is on using advanced nanotechnology to improve cancer treatments through dendritic cell vaccines. The lab investigates how these vaccines can effectively stimulate the immune system to target tumors while minimizing side effects. By employing a cutting-edge imaging technique called magnetic particle imaging, the team aims to better understand how these vaccines migrate to lymph nodes and boost therapeutic efficacy in conditions like melanoma and glioblastoma.

Dr. Gavin R Rumbaugh's lab at the University of Florida focuses on understanding how genetic factors influence brain development and behavior, particularly in the context of neurodevelopmental disorders. The lab investigates how genes associated with disorders like autism and schizophrenia affect the structure and function of circuits in the brain, which are critical for cognitive processing and behavior. Their research uses mouse models to uncover the relationships between gene expression, neural circuit assembly, and behavioral outcomes.

Dr. Marco Salemi's lab focuses on understanding how SARS-CoV-2 evolves in people with compromised immune systems, specifically those with HIV. They develop advanced computational tools using artificial intelligence to predict which viral variants might emerge and spread. This research is crucial for improving public health responses to ongoing and future COVID-19 challenges.

Dr. Cuong Q Nguyen's lab at the University of Florida focuses on understanding Sjogren's Disease, an autoimmune disorder affecting the salivary and lacrimal glands. The lab uses advanced proteomics to uncover unique proteins that could trigger this disease. By identifying these proteins and their interactions with immune cells, the lab aims to discover new therapies to prevent or treat Sjogren's Disease, especially in those who are genetically predisposed.

Dr. Ramon C. Sun's lab at the University of Florida investigates the role of glycogen metabolism in various cancers and Alzheimer's disease. The team is particularly focused on understanding how glycogen influences tumor growth and treatment responses, aiming to develop new diagnostic and therapeutic strategies for Ewing's Sarcoma and lung adenocarcinoma. Their research employs advanced techniques like mass spectrometry imaging to study glycogen and complex carbohydrates in tumor samples, which could lead to personalized patient therapies.

Dr. Ben Shen's lab at the University of Florida focuses on discovering and developing new natural products and cancer therapies. They study actinobacteria, microorganisms known for producing diverse chemical compounds, to identify and produce novel drugs that can potentially treat various diseases, including cancer. The lab also works on improving antibody-drug conjugates, which are treatments that deliver toxins directly to cancer cells, thereby increasing their effectiveness and reducing side effects.

Dr. Rachael D. Seidler's lab focuses on understanding how the brain controls movement and thinking, particularly in older adults at risk for Alzheimer's disease and related conditions. By studying the relationships between walking, cognition, and the brain's vestibular system, the lab aims to identify early indicators of cognitive decline and develop interventions to improve mobility and cognitive function. Their research could help people maintain their independence as they age.

Dr. Gemma Casadesus's lab focuses on understanding how hormonal changes during menopause affect brain health, particularly in relation to Alzheimer's disease (AD). The lab investigates the role of the LH/CG receptor, which is linked to neuroinflammation and cognitive decline. By exploring how this receptor can influence immune responses in the brain, the research aims to uncover potential therapeutic strategies for women at risk of developing AD as they age.

Dr. Patrick Robert Griffin's research lab focuses on understanding how steroid hormone receptors, particularly the progesterone receptor and the retinoic acid receptor-related orphan receptor gamma (RORy), regulate various physiological processes. The lab uses advanced techniques like Cryo-EM and mass spectrometry to uncover the structural dynamics and activities of these receptors in complex with co-regulatory proteins and DNA. By elucidating the mechanistic details of receptor action, the lab aims to develop targeted therapies for diseases that involve these crucial proteins.

Dr. Mei He's lab at the University of Florida focuses on understanding how aging affects the relationship between the brain and muscles, especially in the context of space travel. By studying extracellular vesicles, which are small particles that carry information between cells, the lab aims to uncover potential therapies that could help prevent neurodegenerative diseases like Alzheimer's and Parkinson's. This research could lead to effective ways to keep astronauts healthier during long missions in microgravity and improve aging-related health on Earth as well.

Dr. Christina Boucher's lab at the University of Florida focuses on advancing genome alignment techniques to better represent genetic diversity in human populations. The research aims to create a more inclusive pangenomic reference genome that can improve our understanding of complex traits and diseases like cancer, autism, and schizophrenia. By developing new algorithms and methods for alignment, the lab seeks to enhance the accuracy of genetic analysis and variant detection.

Dr. Thomas J. Kodadek's research lab at the University of Florida focuses on discovering new small molecules that can interact with proteins, particularly those involved in the Ubiquitin Proteasome System (UPS). His team employs cutting-edge DNA-encoded library technology to identify compounds that can manipulate protein degradation pathways, which are essential for maintaining cellular health. Their innovative approach aims to develop drugs that can enhance the body's ability to remove damaged or misfolded proteins, thereby opening new avenues for treating diseases linked to aging and degeneration.

Dr. Mingyi Xie's lab at the University of Florida focuses on understanding how specific small RNAs called microRNAs are regulated in T-cell acute lymphoblastic leukemia (T-ALL). They are investigating a novel mechanism where mRNA can degrade microRNAs, which could lead to new strategies for treating leukemia and overcoming resistance to current therapies. The lab's work could provide insights into gene regulation and potential therapeutic approaches for cancer treatment.